myirislogo
24 October, 2019 03:01 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
Infosys 650.75 1.16
Tata Motors 132.65 0.57
Tata Power 60.80 2.62
Adani Ports 396.25 5.85
State Bank O 275.50 1.87
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Pfizer Limited
Pfizer Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:500680NSE:PFIZERBloomberg:PFIZ@INReuters:PFIZ.BO
Market Lot: 1Face Value: 10ISIN Demat: INE182A01018
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
31-JUL-17 Pfizer disclosed a steep drop in standalone net profit for the quarter ended June 2017. During the quarter, the profit of the company declined 28.57% to Rs 571.70 million from Rs 800.40 million in the same quarter previous year. 01-JUN-17 Pfizer has entered into an acquisition agreement with AstraZeneca AB, Sweden (AstraZeneca), pursuant to which the brand 'Neksium' is being acquired by the company in India for a consideration of Rs ...   More..
Business Profile Future Plans
One To One
Face To Face
We would like to grow above the market and have a whole lot of strategies. We are looking at alliances, brands, lucrative products, line extensions, new delivery systems  Kewal Handa ,finance director
Recent news
Latest News
Pfizer quarterly net declines 29%   -IRIS 31-Jul-17
Previous

More


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)30-Jun-2019(3)31-Mar-2019 (12)31-Mar-2018(12)
Net sales 5444.0020815.0014607.40
Other Income358.301673.901142.90
Total Income5802.3022488.9015750.30
Cost of goods sold-4053.20-15889.8010989.50
OPBDIT9855.5038378.704760.80
PAT1128.104290.502556.60
Gross Block---
Equity capital-0.00457.50
EPS (Rs.)-0.00-
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-NA-
Debt / Equity (x)---
Operating margin (% of OI)169.9170.730.2
Net margin (% of OI)19.419.116.2
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Pfizer Centre
Patel Estate
Off S V Road
Jogeshwari (West)
Mumbai
Maharashtra-400 102
PHONE
(022) 6693 2000
FAX
(022) 2678 4569
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer